Cardiac Surgery, Yale University School of Medicine, New Haven, CT 06510, USA.
J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S5-9; discussion S45-51. doi: 10.1016/j.jtcvs.2010.10.001.
This monograph reviews currently accepted criteria for extirpation of the aneurysmal thoracic aorta. Presence of symptoms suffices to justify resection regardless of size. For asymptomatic patients, resection of the ascending aorta at 5 to 5.5 cm is warranted. The descending aorta can be watched until slightly larger sizes (ie, 5.5-6 cm). Marfan disease or bicuspid aortic valve encourages resection in the smaller region of these size ranges. A nomogram permits adjustment of intervention criteria for extremes of body size. A recently computerized aortic risk calculator automatically applies exponential equations for determination of yearly risk of rupture or dissection for individual patients (available at: http://aorta.yale.edu). Evolving modalities to enhance decision making include positron emission tomography imaging of aneurysm metabolic activity, measurement of mechanical properties of the aorta by echocardiography, and assessment of the biomolecular state of the aneurysm with the "RNA Signature" test.
本专论回顾了目前被接受的胸主动脉瘤切除术标准。有症状足以证明切除是合理的,无论大小如何。对于无症状患者,应在 5 至 5.5 厘米处切除升主动脉。降主动脉可以观察到稍大的尺寸(即 5.5-6 厘米)。马凡综合征或二叶式主动脉瓣鼓励在这些大小范围内较小的区域进行切除。一个图表允许根据身体大小的极端情况调整干预标准。最近开发的计算机化主动脉风险计算器自动应用指数方程,为个体患者确定每年破裂或夹层的风险(可在:http://aorta.yale.edu)。增强决策的新兴方法包括动脉瘤代谢活性的正电子发射断层扫描成像、通过超声心动图测量主动脉的机械性能,以及通过“RNA 特征”测试评估动脉瘤的生物分子状态。